Clinical Trial Update: Safety and Efficacy of a Novel Glucagon Formulation in Type 1 Diabetic Patients Following Insulin-induced Hypoglycemia [Phase 2]

View source ↗

Summary

Phase 2 trial update on a novel glucagon formulation for treating insulin-induced hypoglycemia in type 1 diabetes shows safety and efficacy results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoglycemia
• Type 1 Diabetes Mellitus

Drugs mentioned

• glucagon formulation (novel) (glucagon formulation)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Hypoglycemia | Phase 2 | Status: COMPLETED | Results posted: 2014-08-13